AMWL
American Well Corporation
Price Chart
Latest Quote
$8.82
| Previous Close | $8.78 |
| Open | $8.74 |
| Day High | $8.93 |
| Day Low | $8.61 |
| Volume | 44,317 |
Stock Information
| Shares Outstanding | 15.06M |
| Total Debt | $3.96M |
| Cash Equivalents | $180.00M |
| Revenue | $237.38M |
| Net Income | $-87.88M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $144.03M |
| EPS (TTM) | $-5.43 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-19.22M |
| Sales | $237.38M |
| Income | $-87.88M |
| Book/sh | $13.65 |
| Cash/sh | $11.95 |
| Employees | 562 |
Financial Ratios
| Quick Ratio | 2.83 |
| Current Ratio | 3.09 |
| Debt/Eq | 1.65 |
Returns & Margins
| ROA | -13.43% |
| ROE | -31.84% |
| Gross Margin | 53.80% |
| Operating Margin | -23.59% |
| Profit Margin | -37.02% |
Ownership
| Insider Ownership | 5.36% |
| Institutional Ownership | 45.79% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -5.13 |
| P/S | 0.61 |
| P/B | 0.63 |
Analyst Data
| Recommendation | hold |
| Target Price | $7.50 |
Technical Indicators
| SMA20 | $8.32 |
| SMA50 | $6.90 |
| SMA200 | $5.69 |
| RSI | 62.77 |
| ATR | 0.5226 |
| Shares Float | 11.77M |
| Short Float | 1.66% |
| Short Ratio | 3.24 |
| Volatility | 1.70 |
| Rel Volume | 1.14 |
Performance History
| Week | -12.31% |
| Month | +20.56% |
| Quarter | +57.88% |
| 6 Months | +111.27% |
| YTD | +77.73% |
| Year | +24.57% |
| 3 Years | -80.50% |
| 5 Years | -96.54% |
| 10 Years | -98.13% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $8.62 | 117,700 |
| 2026-06-04 | $8.78 | 93,600 |
| 2026-06-03 | $8.46 | 166,100 |
| 2026-06-02 | $8.50 | 154,600 |
| 2026-06-01 | $9.05 | 293,600 |
| 2026-05-29 | $9.83 | 145,200 |
| 2026-05-28 | $9.46 | 136,600 |
| 2026-05-27 | $8.84 | 242,300 |
| 2026-05-26 | $8.48 | 83,300 |
| 2026-05-22 | $7.96 | 59,700 |
| 2026-05-21 | $7.91 | 19,700 |
| 2026-05-20 | $7.89 | 28,300 |
| 2026-05-19 | $7.83 | 27,800 |
| 2026-05-18 | $7.76 | 62,300 |
| 2026-05-15 | $7.57 | 79,000 |
| 2026-05-14 | $7.78 | 35,500 |
| 2026-05-13 | $7.73 | 35,300 |
| 2026-05-12 | $7.89 | 85,200 |
| 2026-05-11 | $8.15 | 71,100 |
| 2026-05-08 | $7.97 | 119,600 |
| 2026-05-07 | $7.75 | 94,100 |
| 2026-05-06 | $7.15 | 191,300 |
About American Well Corporation
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
đ° Latest News
Why Fast-paced Mover American Well (AMWL) Is a Great Choice for Value Investors
Zacks âĸ 2026-06-02T12:55:01ZIs Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
Zacks âĸ 2026-05-25T13:40:04ZShifting Narrative For American Well (AMWL) As Analysts Debate The New US$7.50 Target
Simply Wall St. âĸ 2026-05-22T17:08:41ZHims & Hers Expands Digital Healthcare Platform via New Care Offerings
Zacks âĸ 2026-05-11T15:45:00ZAmerican Well (AMWL) Upgraded to Buy: Here's What You Should Know
Zacks âĸ 2026-05-08T16:00:05ZHas Butterfly Network (BFLY) Outpaced Other Medical Stocks This Year?
Zacks âĸ 2026-05-08T13:40:02ZDespite Fast-paced Momentum, American Well (AMWL) Is Still a Bargain Stock
Zacks âĸ 2026-05-08T12:55:01ZAmerican Well Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-06T12:30:00ZAmerican Well Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T05:08:56ZAmerican Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-06T00:30:04ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $116,468,000 | $155,414,000 | $164,267,000 | $160,408,000 |
| Cost Of Revenue | $116,467,000 | $155,412,000 | $164,287,000 | $160,422,000 |
| Total Revenue | $249,325,000 | $254,364,000 | $259,047,000 | $277,190,000 |
| Operating Revenue | $226,693,000 | $231,999,000 | $231,846,000 | $245,269,000 |
| Expenses | ||||
| Total Expenses | $354,599,000 | $471,898,000 | $514,711,000 | $553,043,000 |
| Other Income Expense | $8,634,000 | - | $-436,479,000 | - |
| Net Non Operating Interest Income Expense | $3,803,000 | $10,757,000 | $19,422,000 | $6,123,000 |
| Operating Expense | $238,132,000 | $316,486,000 | $350,424,000 | $392,621,000 |
| Selling And Marketing Expense | $43,265,000 | $76,272,000 | $86,460,000 | $81,628,000 |
| General And Administrative Expense | $88,045,000 | $121,174,000 | $126,645,000 | $146,353,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-95,700,000 | $-208,143,000 | $-675,164,000 | $-270,429,000 |
| Net Interest Income | $3,803,000 | $10,757,000 | $19,422,000 | $6,123,000 |
| Interest Income | $3,803,000 | $10,757,000 | $19,422,000 | $6,123,000 |
| Normalized Income | $-102,520,860 | $-208,143,000 | $-330,345,590 | $-270,429,000 |
| Net Income From Continuing And Discontinued Operation | $-95,700,000 | $-208,143,000 | $-675,164,000 | $-270,429,000 |
| Total Operating Income As Reported | $-105,274,000 | $-217,534,000 | $-692,143,000 | $-275,853,000 |
| Net Income Common Stockholders | $-95,700,000 | $-208,143,000 | $-675,164,000 | $-270,429,000 |
| Net Income | $-95,700,000 | $-208,143,000 | $-675,164,000 | $-270,429,000 |
| Net Income Including Noncontrolling Interests | $-94,967,000 | $-212,638,000 | $-679,171,000 | $-272,072,000 |
| Net Income Continuous Operations | $-94,967,000 | $-212,638,000 | $-679,171,000 | $-272,072,000 |
| Earnings From Equity Interest Net Of Tax | $-1,696,000 | $-3,110,000 | $-2,590,000 | $-2,278,000 |
| Pretax Income | $-92,837,000 | $-206,777,000 | $-672,721,000 | $-269,730,000 |
| Special Income Charges | $8,634,000 | $0 | $-436,479,000 | $0 |
| Interest Income Non Operating | $3,803,000 | $10,757,000 | $19,422,000 | $6,123,000 |
| Operating Income | $-105,274,000 | $-217,534,000 | $-255,664,000 | $-275,853,000 |
| Depreciation Amortization Depletion Income Statement | $33,961,000 | $32,975,000 | $31,492,000 | $26,153,000 |
| Depreciation And Amortization In Income Statement | $33,961,000 | $32,975,000 | $31,492,000 | $26,153,000 |
| Gross Profit | $132,858,000 | $98,952,000 | $94,760,000 | $116,768,000 |
| Per Share | ||||
| Diluted EPS | $-5.96 | $-13.88 | $-47.60 | $-19.80 |
| Basic EPS | $-5.96 | $-13.88 | $-47.60 | $-19.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,813,140 | $0 | $-91,660,590 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-79,947,000 | $-184,559,000 | $212,327,000 | $-249,686,000 |
| Total Unusual Items | $8,634,000 | $0 | $-436,479,000 | $0 |
| Total Unusual Items Excluding Goodwill | $8,634,000 | $0 | $-436,479,000 | $0 |
| Reconciled Depreciation | $33,960,000 | $32,973,000 | $31,512,000 | $26,167,000 |
| EBITDA (Bullshit earnings) | $-71,313,000 | $-184,559,000 | $-224,152,000 | $-249,686,000 |
| EBIT | $-105,274,000 | $-217,534,000 | $-255,664,000 | $-275,853,000 |
| Diluted Average Shares | $16,047,452 | $14,999,590 | $14,212,837 | $13,712,487 |
| Basic Average Shares | $16,047,452 | $14,999,590 | $14,212,837 | $13,712,487 |
| Diluted NI Availto Com Stockholders | $-95,700,000 | $-208,143,000 | $-675,164,000 | $-270,429,000 |
| Minority Interests | $-733,000 | $4,495,000 | $4,007,000 | $1,643,000 |
| Tax Provision | $434,000 | $2,751,000 | $3,860,000 | $64,000 |
| Gain On Sale Of Business | $8,634,000 | $0 | $0 | - |
| Impairment Of Capital Assets | $0 | $0 | $436,479,000 | $0 |
| Research And Development | $72,861,000 | $86,065,000 | $105,827,000 | $138,487,000 |
| Selling General And Administration | $131,310,000 | $197,446,000 | $213,105,000 | $227,981,000 |
| Other Gand A | $88,045,000 | $121,174,000 | $126,645,000 | $146,353,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $169,510,000 | $203,234,000 | $343,971,000 | $493,618,000 |
| Total Assets | $323,787,000 | $435,968,000 | $589,705,000 | $1,217,557,000 |
| Total Non Current Assets | $77,106,000 | $118,975,000 | $140,123,000 | $590,941,000 |
| Other Non Current Assets | $2,419,000 | $3,008,000 | $2,878,000 | $2,767,000 |
| Non Current Deferred Assets | $4,459,000 | $5,350,000 | $4,792,000 | $3,394,000 |
| Goodwill And Other Intangible Assets | $66,073,000 | $101,538,000 | $120,248,000 | $570,259,000 |
| Other Intangible Assets | $66,073,000 | $101,538,000 | $120,248,000 | $134,980,000 |
| Current Assets | $246,681,000 | $316,993,000 | $449,582,000 | $626,616,000 |
| Other Current Assets | $10,813,000 | $11,421,000 | $14,484,000 | $19,567,000 |
| Current Deferred Assets | $2,660,000 | $2,513,000 | $2,262,000 | $1,394,000 |
| Inventory | $1,187,000 | $2,858,000 | $6,652,000 | $8,737,000 |
| Receivables | $49,693,000 | $71,885,000 | $54,146,000 | $58,372,000 |
| Accounts Receivable | $49,693,000 | $71,885,000 | $54,146,000 | $58,372,000 |
| Allowance For Doubtful Accounts Receivable | $-9,463,000 | $-7,236,000 | $-2,291,000 | $-1,884,000 |
| Gross Accounts Receivable | $59,156,000 | $79,121,000 | $56,437,000 | $60,256,000 |
| Cash Cash Equivalents And Short Term Investments | $182,328,000 | $228,316,000 | $372,038,000 | $538,546,000 |
| Cash And Cash Equivalents | $182,328,000 | $228,316,000 | $372,038,000 | $538,546,000 |
| Restricted Cash | - | - | - | - |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $4,524,000 | $8,201,000 | $11,786,000 | $14,844,000 |
| Long Term Debt And Capital Lease Obligation | $892,000 | $4,511,000 | $8,206,000 | $11,787,000 |
| Current Debt And Capital Lease Obligation | $3,632,000 | $3,690,000 | $3,580,000 | $3,057,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $75,999,000 | $119,724,000 | $109,519,000 | $133,706,000 |
| Total Non Current Liabilities Net Minority Interest | $2,785,000 | $8,461,000 | $15,722,000 | $19,650,000 |
| Other Non Current Liabilities | $1,075,000 | $1,170,000 | $1,425,000 | $1,574,000 |
| Non Current Deferred Liabilities | $818,000 | $2,780,000 | $6,091,000 | $6,289,000 |
| Current Liabilities | $73,214,000 | $111,263,000 | $93,797,000 | $114,056,000 |
| Other Current Liabilities | $12,170,000 | $10,086,000 | $12,140,000 | $9,780,000 |
| Current Deferred Liabilities | $22,625,000 | $53,232,000 | $46,365,000 | $49,505,000 |
| Payables And Accrued Expenses | $12,231,000 | $18,267,000 | $16,139,000 | $25,522,000 |
| Payables | $1,649,000 | $5,015,000 | $4,864,000 | $7,236,000 |
| Accounts Payable | $1,649,000 | $5,015,000 | $4,864,000 | $7,236,000 |
| Equity | ||||
| Common Stock Equity | $235,583,000 | $304,772,000 | $464,219,000 | $1,063,877,000 |
| Total Equity Gross Minority Interest | $247,788,000 | $316,244,000 | $480,186,000 | $1,083,851,000 |
| Stockholders Equity | $235,583,000 | $304,772,000 | $464,219,000 | $1,063,877,000 |
| Gains Losses Not Affecting Retained Earnings | $-12,099,000 | $-15,840,000 | $-15,650,000 | $-16,969,000 |
| Other Equity Adjustments | $-12,099,000 | $-15,840,000 | $-15,650,000 | $-16,969,000 |
| Retained Earnings | $-2,061,628,000 | $-1,965,924,000 | $-1,757,778,000 | $-1,082,028,000 |
| Long Term Equity Investment | $0 | $1,500,000 | $1,180,000 | $0 |
| Other | ||||
| Ordinary Shares Number | $16,430,083 | $15,570,172 | $14,424,424 | $13,856,983 |
| Share Issued | $16,430,083 | $15,570,172 | $14,424,424 | $13,856,983 |
| Tangible Book Value | $169,510,000 | $203,234,000 | $343,971,000 | $493,618,000 |
| Invested Capital | $235,583,000 | $304,772,000 | $464,219,000 | $1,063,877,000 |
| Working Capital | $173,467,000 | $205,730,000 | $355,785,000 | $512,560,000 |
| Capital Lease Obligations | $4,524,000 | $8,201,000 | $11,786,000 | $14,844,000 |
| Total Capitalization | $235,583,000 | $304,772,000 | $464,219,000 | $1,063,877,000 |
| Minority Interest | $12,205,000 | $11,472,000 | $15,967,000 | $19,974,000 |
| Additional Paid In Capital | $2,309,145,000 | $2,286,380,000 | $2,237,502,000 | $2,160,108,000 |
| Capital Stock | $165,000 | $156,000 | $145,000 | $2,766,000 |
| Common Stock | $165,000 | $156,000 | $145,000 | $2,766,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $818,000 | $2,780,000 | $6,091,000 | $6,289,000 |
| Long Term Capital Lease Obligation | $892,000 | $4,511,000 | $8,206,000 | $11,787,000 |
| Current Deferred Revenue | $22,625,000 | $53,232,000 | $46,365,000 | $49,505,000 |
| Current Capital Lease Obligation | $3,632,000 | $3,690,000 | $3,580,000 | $3,057,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $22,556,000 | $25,988,000 | $15,573,000 | $26,192,000 |
| Current Accrued Expenses | $10,582,000 | $13,252,000 | $11,275,000 | $18,286,000 |
| Investments And Advances | $0 | $1,500,000 | $1,180,000 | $0 |
| Investmentsin Joint Venturesat Cost | $0 | $1,500,000 | $1,180,000 | $0 |
| Net PPE | $4,155,000 | $7,579,000 | $11,025,000 | $14,521,000 |
| Accumulated Depreciation | $-11,333,000 | $-13,088,000 | $-12,799,000 | $-12,168,000 |
| Gross PPE | $15,488,000 | $20,667,000 | $23,824,000 | $26,689,000 |
| Leases | $177,000 | $685,000 | $692,000 | $692,000 |
| Other Properties | $3,930,000 | $7,203,000 | $10,453,000 | $13,509,000 |
| Machinery Furniture Equipment | $11,381,000 | $12,779,000 | $12,679,000 | $12,488,000 |
| Properties | $0 | $0 | $0 | $0 |
| Goodwill | - | - | $0 | $435,279,000 |
| Treasury Stock | - | - | - | - |
| Other Short Term Investments | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-65,974,000 | $-142,560,000 | $-163,591,000 | $-202,770,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-65,953,000 | $-127,338,000 | $-148,343,000 | $-192,323,000 |
| Cash Flow From Continuing Operating Activities | $-65,953,000 | $-127,338,000 | $-148,343,000 | $-192,323,000 |
| Operating Gains Losses | $-6,938,000 | $3,110,000 | $2,590,000 | $2,278,000 |
| Investing Activities | ||||
| Capital Expenditure | $-21,000 | $-15,222,000 | $-15,248,000 | $-10,447,000 |
| Investing Cash Flow | $17,104,000 | $-18,652,000 | $-19,168,000 | $-11,630,000 |
| Cash Flow From Continuing Investing Activities | $17,104,000 | $-18,652,000 | $-19,168,000 | $-11,630,000 |
| Capital Expenditure Reported | $0 | $-15,103,000 | $-15,056,000 | $-10,155,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-4,000 | $-3,000 | $-586,000 | $-360,000 |
| Financing Cash Flow | $840,000 | $1,381,000 | $2,147,000 | $-3,612,000 |
| Cash Flow From Continuing Financing Activities | $840,000 | $1,381,000 | $2,147,000 | $-3,612,000 |
| Net Common Stock Issuance | $-4,000 | $-3,000 | $-586,000 | $-360,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Other Financing Charges | - | - | - | $-11,495,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Income Tax Paid Supplemental Data | $1,969,000 | $4,105,000 | $5,003,000 | $1,723,000 |
| End Cash Position | $183,123,000 | $229,111,000 | $372,833,000 | $539,341,000 |
| Beginning Cash Position | $229,111,000 | $372,833,000 | $539,341,000 | $747,211,000 |
| Effect Of Exchange Rate Changes | $2,021,000 | $887,000 | $-1,144,000 | $-305,000 |
| Changes In Cash | $-48,009,000 | $-144,609,000 | $-165,364,000 | $-207,565,000 |
| Proceeds From Stock Option Exercised | $844,000 | $1,384,000 | $2,733,000 | $8,243,000 |
| Common Stock Payments | $-4,000 | $-3,000 | $-586,000 | $-360,000 |
| Net Investment Purchase And Sale | $-1,000,000 | $0 | $0 | $777,000 |
| Sale Of Investment | $0 | $0 | $389,990,000 | $500,000,000 |
| Purchase Of Investment | $-1,000,000 | $0 | $-389,990,000 | $-499,223,000 |
| Net Business Purchase And Sale | $18,125,000 | $-3,430,000 | $-3,920,000 | $-1,960,000 |
| Sale Of Business | $18,321,000 | $0 | $0 | - |
| Purchase Of Business | $-196,000 | $-3,430,000 | $-3,920,000 | $-1,960,000 |
| Net PPE Purchase And Sale | $-21,000 | $-119,000 | $-192,000 | $-292,000 |
| Purchase Of PPE | $-21,000 | $-119,000 | $-192,000 | $-292,000 |
| Change In Working Capital | $-26,795,000 | $-9,981,000 | $-15,507,000 | $-28,096,000 |
| Change In Other Working Capital | $-34,776,000 | $469,000 | $-7,958,000 | $-22,510,000 |
| Change In Other Current Assets | $779,000 | $-217,000 | $-76,000 | $-235,000 |
| Change In Payables And Accrued Expense | $-7,060,000 | $10,277,000 | $-17,500,000 | $4,182,000 |
| Change In Accrued Expense | $-3,642,000 | $10,118,000 | $-15,139,000 | $8,962,000 |
| Change In Payable | $-3,418,000 | $159,000 | $-2,361,000 | $-4,780,000 |
| Change In Account Payable | $-3,418,000 | $159,000 | $-2,361,000 | $-4,780,000 |
| Change In Prepaid Assets | $871,000 | $2,601,000 | $4,694,000 | $-161,000 |
| Change In Inventory | $1,171,000 | $1,901,000 | $2,085,000 | $-1,207,000 |
| Change In Receivables | $12,220,000 | $-25,012,000 | $3,248,000 | $-8,140,000 |
| Changes In Account Receivables | $12,220,000 | $-25,012,000 | $3,248,000 | $-8,140,000 |
| Other Non Cash Items | $4,643,000 | $2,916,000 | $2,693,000 | $13,443,000 |
| Stock Based Compensation | $22,010,000 | $47,542,000 | $72,246,000 | $67,675,000 |
| Provisionand Write Offof Assets | $2,744,000 | $7,090,000 | $1,057,000 | $806,000 |
| Asset Impairment Charge | $500,000 | $1,893,000 | $436,479,000 | $0 |
| Deferred Tax | $-1,110,000 | $-243,000 | $-242,000 | $-2,524,000 |
| Deferred Income Tax | $-1,110,000 | $-243,000 | $-242,000 | $-2,524,000 |
| Depreciation Amortization Depletion | $33,960,000 | $32,973,000 | $31,512,000 | $26,167,000 |
| Depreciation And Amortization | $33,960,000 | $32,973,000 | $31,512,000 | $26,167,000 |
| Earnings Losses From Equity Investments | $1,696,000 | $3,110,000 | $2,590,000 | $2,278,000 |
| Gain Loss On Sale Of Business | $-8,634,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $-94,967,000 | $-212,638,000 | $-679,171,000 | $-272,072,000 |
| Change In Other Current Liabilities | - | $0 | $0 | $-25,000 |